123 - Uncovering HUGE Quality Issues, Inspection Readiness in 2024, Data Integrity, AlCOA+/PIC/S and Critical Thinking in Quality Management with Peter Baker

Let's Combinate · 14 Feb 2024 · 45m

What this episode covers

Peter Baker, President of Live Oak Quality Assurance and former FDA Drug Investigator, discusses his career uncovering data integrity breaches in overseas manufacturing facilities. He explains that 99% of data integrity issues stem from poor process design and 'right environment' failures rather than human error, urging companies to shift from compliance-focused checklists to quality-driven critical thinking. Baker highlights specific field failures, such as the manipulation of product quality by blending failed batches with passing ones, and emphasizes the importance of honest reporting of unknown discrepancies to ensure patient safety.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 30m

    What are the Top Compliance Issues Plaguing Medical Device Manufacturers?

    Tom Rynkiewicz, VP of RA/QA at Raland Compliance Partners, joins host John Spear to discuss the top compliance issues plaguing medical device manufacturers, specifically CAPA, complaints, and design controls. Rynkiewicz argues that these recurring FDA observations stem from flawed internal audit practices that audit isolated quality system components rather than the entire system holistically. He highlights how human behavior and corporate KPIs, such as tracking CAPA turnaround times instead of effectiveness, prevent companies from achieving a true quality culture with zero complaints. The conversation emphasizes the need for system-level auditing and transparency to prepare for potential FDA shifts toward stricter Good Manufacturing Practices (GMP) inspections.

  • Global Medical Device Podcast · 44m

    Most Common Problems Found During FDA Inspections in 2022

    Mike Drues, President of Vascular Sciences, analyzes the FDA's 2022 inspection data to identify the most common reasons for Form 483s, highlighting CAPA, design controls, and complaint handling as the top three issues. He argues that these problems persist because companies focus on ticking regulatory boxes rather than understanding the underlying intent, often failing to perform adequate root cause analysis or document their quality management systems effectively. Drues emphasizes that medical device professionals must move beyond minimum compliance to prevent recurring errors and ensure patient safety through proactive prevention and rigorous validation.

  • Global Medical Device Podcast · 44m

    #384: Insights from an Ex-FDA Investigator: Compliance, Quality Systems, and MedTech Trends

    Vincent Cafiso, Director of Quality and Regulatory Services at Creo Consulting and former FDA investigator, discusses the critical need for MedTech companies to align R&D testing environments with production standards to avoid costly rework and data rejection. He highlights common pitfalls in design controls, such as missing real-time aging data and inadequate documentation in Design History Files, urging companies to integrate quality validation early in the development process. Cafiso also emphasizes the importance of management responsibility and breaking down organizational silos through skip-level meetings to maintain a collaborative, startup-like culture as companies scale from garage startups to enterprise levels.

  • Global Medical Device Podcast · 45m

    Quality Myths and Lessons Learned

    Kevin Becker, author of 'Quality Myths and Lessons Learned' and Director of Quality at a med device component manufacturer, discusses common pitfalls in medical device quality engineering. He explains how misaligned incentives can lead to unethical behavior, such as falsifying data or hiding defects during FDA audits, and emphasizes the need for principle-based decision-making to overcome peer pressure and 'normalization of deviance.' Becker argues that management support is the most critical component of a Quality Management System (QMS) and shares lessons on statistical misconceptions, effective flowcharting, and the importance of integrity in engineering.

  • Global Medical Device Podcast · 34m

    Top 3 Most Cited Issues in Medical Device Inspections from FDA FY2020

    Jon Speer, founder of Greenlight Guru, interviews Mike Drues, president of Vascular Sciences, about the FDA's FY2020 inspection data for medical device quality systems. They analyze the top three most cited 483 observations: CAPA, complaints, and design controls, noting that these accounted for approximately 35% of all findings. Drues and Speer discuss the critical failure of manufacturers to document procedures, investigate complaints, and use production-equivalent devices for validation, emphasizing that these are basic regulatory requirements rather than complex nuances.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.